Other Lipid Assays from Randox
Randox is a leading provider of diagnostic reagents for the assessment of cardiovascular disease risk. Our extensive menu of cardiac biomarkers offers superior performance and is available for use on a wide range of chemistry analysers.
Cardiovascular disease (CVD) and more specifically, Myocardial Infarction (MI) remains a leading cause of morbidity and mortality, despite the targeting of LDL cholesterol via statin therapy. There is a need for additional causal risk factors, beyond the traditional LDL measurement¹.
The lipid profile is perhaps the most important of the cardiac risk tests providing a good indication of whether someone is likely to have a coronary event caused by a blockage of the blood vessels or atherosclerosis. The Randox lipid profile includes the following tests:
In addition to conventional risk factors such as the lipid profile there are several other emerging biomarkers associated with an increased risk of cardiovascular disease.
Extended Lipid Profile
Emerging Risk Factors
1. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009;301:2331-2339.